Cargando…
In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal
Non-alcoholic fatty liver disease (NAFLD), including non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH), represents the hepatic manifestation of obesity and metabolic syndrome. Due to the spread of the obesity epidemic, NAFLD is becoming the most common chronic liver disease a...
Autores principales: | Soret, Pierre-Antoine, Magusto, Julie, Housset, Chantal, Gautheron, Jérémie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794936/ https://www.ncbi.nlm.nih.gov/pubmed/33374435 http://dx.doi.org/10.3390/jcm10010036 |
Ejemplares similares
-
The necroptosis-inducing pseudokinase mixed lineage kinase domain-like regulates the adipogenic differentiation of pre-adipocytes
por: Magusto, Julie, et al.
Publicado: (2022) -
Multiple functions of MLKL in liver fibrosis, from necroptosis to hepatic stellate cell activation
por: Pistorio, Valeria, et al.
Publicado: (2022) -
In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Kanuri, Giridhar, et al.
Publicado: (2013) -
A Critical Appraisal of the Definition of Sarcopenia in Patients with Non-Alcoholic Fatty Liver Disease: Pitfall of Adjusted Muscle Mass by Body Weight
por: Park, Huiyul, et al.
Publicado: (2020) -
Long‐term prognostic value of the FibroTest in patients with non‐alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease
por: Munteanu, Mona, et al.
Publicado: (2018)